Genfit S.A.
Biopharmaceutical firm developing therapies and diagnostics for liver diseases.
GNFT | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- PARC EURASANTE, 59120 LOOS
- Website:
- https://www.genfit.fr/
- Sector:
- Manufacturing
Description
Genfit S.A. is a late-stage biopharmaceutical company dedicated to discovering and developing therapeutic solutions for severe and life-threatening liver diseases with high unmet medical needs. The company's pipeline focuses on drug candidates with complementary mechanisms of action that target key pathophysiological pathways in conditions such as Acute-on-Chronic Liver Failure (ACLF). A key asset, developed in partnership with Ipsen, received accelerated approval from the U.S. FDA for a chronic liver disease. This therapy works by activating specific receptors to reduce inflammation and manage bile acids. Genfit also develops diagnostic solutions and strategically expands its portfolio through acquisitions and licensing agreements to advance its research in liver disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Genfit S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genfit S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genfit S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
